Endocrinology
From the Journals
Body fat linked to lower bone density, particularly in men
“Lean and fat mass affect bone density differently and that obesity is not a guarantee against osteoporosis.”
From the Journals
Heavy cannabis use tied to less diabetes in women
Women, but not men, who used marijuana at least four times in the previous month were less likely to have type 2 diabetes than nonusers, found a...
News
Endocrine Society and others to FDA: Restrict BPA
A petition requests that prior approvals of bisphenol A, a chemical contained in food packaging be removed, citing recent evidence of harm.
From the Journals
Anxiety in men tied to risk factors for CVD, diabetes
Worry and neuroticism, both aspects of anxiety, when seen in midlife are associated with differences in risk for heart disease and diabetes that...
From the Journals
Chronic stress accelerates aging: Epigenetic evidence
The greater the psychologic resilience, the more likely the individual is to live a long and healthy life.
From the Journals
‘Lucky genes’ may protect against some obesity-related diseases
Good genes [are] still no substitute for a healthy lifestyle, said Dr. Susan Martin.
From the Journals
Men with hypersexual disorder may have oxytocin overload
Cognitive-behavioral therapy reduced both oxytocin levels and hypersexual behavior.
From the Journals
Vitamin D shows no survival benefit in nondeficient elderly
“This is not dissimilar to research with many other nutrients showing that increasing intake above the adequate intake has no further health...
News
FDA okays first tubing-free ‘artificial pancreas’ Omnipod 5
The system automatically adjusts insulin levels based on individual settings and predictive technology.
From the Journals
‘Physiology fights back’ when people are trying to lose weight
“Individuals who are struggling to achieve weight-loss goals, despite assuring compliance with [a] diet, may indeed be ‘suffering’ from metabolic...
Feature
Uptake uncertain for potent new LDL-lowerer inclisiran
Inclisiran, a novel small interfering RNA drug that inhibits PCSK9, made its U.S. debut in early 2022 with cautious uptake prospects.